NOVEL HPLC-UV METHOD USING VOLATILE BUFFER FOR SIMULTANEOUS DETERMINATION OF AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM

Authors

  • Pham Duy Toan Department of Pharmaceutical Technology, Faculty of Pharmacy, Can Tho University of Medicine and Pharmacy, Can Tho, Vietnam
  • Pham Phan Anh Minh
  • Duong Thi Truc Ly

Keywords:

Amlodipine, Atorvastatin, Simultaneous, Dissolution, HPLC, Quantification, Volatile buffer

Abstract

Objective: The purpose of this work was to develop and validate a novel HPLC-UV method using triethylamine (TEA) as a volatile buffer for simultaneous determination of amlodipine besylate (AML) and atorvastatin calcium (ATV).

Methods: System suitability, linearity, limit of detection (LOD), limit of quantification (LOQ), selectivity, accuracy, and precision was validated using Hitachi L-2000 system with detector: DAD L-2455 at a detected wavelength of 245 nm. Stationary phase: Phenomenex Luna RP-C18 (250 mm x 4.6 mm, 5 µm) and mobile phase: acetonitrile-methanol-TEA pH 4.0 (ratio 52:18:30 v/v/v) were used. Samples' volume of 20 µl was run at room temperature with the flow rate at 1 ml/min.

Results: The linearity demonstrated good correlation in the concentration range at 2-40 ppm and 4-80 ppm for AML and ATV, respectively. The method was repeatable with relative standard deviation (RSD) of the intermediate precision test less than 1%. The recovery rate was 100.03% and 99.58% for AML and ATV, respectively. The method was also validated for dissolution studies with excellent compatibility.

Conclusion: A new, simple and easy HPLC-UV method was successfully developed and validated for the determination of AML and ATV in both quantification test and dissolution test.

Keywords: Amlodipine, Atorvastatin, Simultaneous, Dissolution, HPLC, Quantification, Volatile buffer

Downloads

Download data is not yet available.

References

World Health Organization. Media Center: Cardiovascular diseases; 2015. Available from: http://www.who.int/ mediacentre/ factsheets/fs317/en/. [Last accessed on 20 Mar 2016].

Eyal L, Maya B, Reuven Z, Angela F, Dov G. Treatment with amlodipine and atorvastatin have an additive effect in improvement of arterial elasticity in hypertensive, hyperlipidemic patients. Am J Hypertens 2003;16:715-8.

Dorval JF, Anderson T, Buithieu J, Chan S, Hutchison S, Huynh T, et al. Reaching recommended lipid and blood pressure targets with amlodipine/atorvastatin combination in patients with coronary heart disease. Am J Cardiol 2005;95:249-53.

Cowie MR. Simultaneous treatment of hypertension and dyslipidemia may help to reduce overall cardiovascular risk: focus on amlodipine/atorvastatin single pill therapy. Int J Clin Pract 2005;59:839-46.

Devi R, Ramakrishna S. New spectrophotometric methods for simultaneous determination of amlodipine besylate and atorvastatin calcium in tablet dosage forms. Int J Pharm Pharm Sci 2010;2:215-9.

Darwish HW, Hassan SA, Salem MY, El-Zeiny BA. Three different spectrophotometric methods manipulating ratio spectra for determination of a binary mixture of amlodipine and atorvastatin. Spectrochim Acta Part A 2011;83:140-8.

Mohammadi A, Rezanour N, Ansari Dogaheh M, Ghorbani Bidkorbeh F, Hashem M, Walker RB. A stability-indicating high performance liquid chromatographic (HPLC) assay for the simultaneous determination of atorvastatin and amlodipine in commercial tablets. J Chromatogr B: Anal Technol Biomed Life Sci 2007;846:215-21.

Jena A, Madhu M, Latha S. Analytical method development and validation of simultaneous determination of atorvastatin calcium and amlodipine besilate in tablet dosage form by RC-HPLC. Int J Pharm Sci Res 2010;1:100-6.

Varun A, Pragi A, Lamba HS. Simultaneous estimation of atorvastatin and amlodipine besilate in pharmaceutical formulation by a novel HPLC method. Int J Pharm Chem Sci 2012;1:329-31.

Yacoub M, Awwad AA, Alawi M, Arafat T. Simultaneous determination of amlodipine and atorvastatin with its metabolites; ortho and para hydroxy atorvastatin; in human plasma by LC-MS/MS. J Chromatogr B: Anal Technol Biomed Life Sci 2013;917-918:36-47.

Qiyu H, Zhe-Yi H, Fan-Yuan Z, Jin-Hui Z, Li-Li W, Yan L, et al. HPLC-MS-MS for the simultaneous determination of atorvastatin and amlodipine in plasma of hypertensive patients. Chromatographia 2011;73:257-62.

Mohamed MH, Maha S, Al-Johara H. Development of capillary electrophoresis technique for simultaneous measurement of amlodipine and atorvastatin from their combination drug formulations. J Liq Chromatogr 2009;32:2923-42.

Lloyd RS, Joseph JK, John WD. Bonded-phase chromatography. In: Lloyd RS, Joseph JK, John WD. Introduction to modern liquid chromatography. 3rd ed. John Wiley and Sons, Inc; 2010. p. 29, 309-16, 882.

International conference on harmonization, Guidelines on validation of analytical procedure: Definitions and terminology, Q2A, Geneva: IFPMA; 1995.

International conference on harmonization, Guidelines on validation of analytical procedure: methodology, Q2B, Geneva: IFPMA; 1996.

Gjelstrup KH, Schaefer T. Granulation a review on pharmaceutical wet-granulation. Drug Dev Ind Pharm 1987;13:803-72.

Published

01-07-2016

How to Cite

Toan, P. D., P. P. A. Minh, and D. T. Truc Ly. “NOVEL HPLC-UV METHOD USING VOLATILE BUFFER FOR SIMULTANEOUS DETERMINATION OF AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM”. International Journal of Pharmacy and Pharmaceutical Sciences, vol. 8, no. 7, July 2016, pp. 365-8, https://journals.innovareacademics.in/index.php/ijpps/article/view/12202.

Issue

Section

Original Article(s)